General Information of the Compound
| Compound ID |
CP0381529
|
||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Compound Name |
3-[4-[[4-(4-amino-6,7-dimethoxyquinazolin-2-yl)piperazin-1-yl]methyl]triazol-1-yl]-7-(diethylamino)chromen-2-one
Show/Hide
|
||||||||||||||||||
| Structure |
|
||||||||||||||||||
| Formula |
C30H35N9O4
|
||||||||||||||||||
| Molecular Weight |
585.669
|
||||||||||||||||||
| Canonical SMILES |
CCN(CC)c1ccc2cc(-n3cc(CN4CCN(CC4)c4nc(N)c5cc(OC)c(OC)cc5n4)nn3)c(=O)oc2c1
Show/Hide
|
||||||||||||||||||
| InChI |
InChI=1S/C30H35N9O4/c1-5-37(6-2)21-8-7-19-13-24(29(40)43-25(19)14-21)39-18-20(34-35-39)17-36-9-11-38(12-10-36)30-32-23-16-27(42-4)26(41-3)15-22(23)28(31)33-30/h7-8,13-16,18H,5-6,9-12,17H2,1-4H3,(H2,31,32,33)
Show/Hide
|
||||||||||||||||||
| InChIKey |
KDSUSJUAJOGNPC-UHFFFAOYSA-N
|
||||||||||||||||||
| Physicochemical Property |
"RO5" indicates the cutoff set by lipinski's rule of five: (1) Molecular weight less than 500 Dalton; (2) xlogp less than 5; (3) No more than 5 hbonddonor (Hydrogen Bond Donor Count); (4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count); (5) No more than 10 rotbonds (Rotatable Bond Count). Show/Hide
|
||||||||||||||||||
| Click to Show/Hide the External Link(s) of This Compound | |||||||||||||||||||
| PubChem ID | |||||||||||||||||||
| ChEMBL ID | |||||||||||||||||||
Map of Molecular Bioactivity Related to the Compound
|
Map of Molecular Bioactivity Related to the Compound Compound Cell Line Protein Bioactivity Value: <= 0.1 μM > 0.1 μM and <= 10 μM > 10 μM Imprecise Activity |
|
|---|
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT01089, Alpha-1A adrenergic receptor
Protein ID: PT01007, Alpha-1B adrenergic receptor
Protein ID: PT01004, Alpha-1D adrenergic receptor
Cell Viability or Cytotoxicity Assay
| Cell Line ID | Cell Line Name | Cell Line Organism | |
| CL000050 | HEK293-A | Homo sapiens (Human) | 1 |
| 1 |
IC50 = 17000 nM
|
TI
LI
LO
TS
|
|
|---|---|---|---|